Drug Shortage Report for AVELOX I.V.
| Report ID | 12543 |
| Drug Identification Number | 02246414 |
| Brand name | AVELOX I.V. |
| Common or Proper name | moxifloxacin injection |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MOXIFLOXACIN |
| Strength(s) | 400MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 250 mL Ready-to-use minibag |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-06-30 |
| Actual start date | |
| Estimated end date | 2018-03-29 |
| Actual end date | 2018-02-23 |
| Shortage status | Resolved |
| Updated date | 2018-02-27 |
| Company comments | Avelox I.V. is now in bottle and available to the market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-02-27 | French | Compare |
| v6 | 2018-02-27 | English | Compare |
| v5 | 2018-02-27 | French | Compare |
| v4 | 2018-02-27 | English | Compare |
| v3 | 2017-07-01 | English | Compare |
| v2 | 2017-06-12 | French | Compare |
| v1 | 2017-06-12 | English | Compare |
Showing 1 to 7 of 7